We’re proud that the @lifearc.bsky.social Centre for Rare Mitochondrial Diseases has officially launched at a prestigious House of Lords event – a significant milestone in transforming the UK’s rare disease research landscape

Stay tuned to meet the lead minds behind the centre on our Research Zone!

🚨 Final call to register for the Cambridge Eye Trust Research Day!
🗓️ 17 June 2025 | 09:30–14:00
📍 Li Ka Shing Centre, Cambridge
🎤 Keynote: Prof David Huang – OCT: My Personal Journey to Discovery
👉 www.cambridgeeyetrust.org.uk/meeting-regi...
#Ophthalmology #OCT #VisionScience

Thanks to @lilyfoundation.bsky.social for an eye-opening #PPIE workshop, and to @lifearc.bsky.social for a really exciting day overall outlining research strategies and new collaborations!

Really excited to see the progress over the next few years!

@mitocamb.bsky.social

2x CRA posts extended until end of April. So you have another chance to work with #mito disease patients as part of the @lifearc.bsky.social centre for #rare #mito diseases! See links below to apply!
@eastgenomics.bsky.social @camneuro.bsky.social @cuhnhs.bsky.social

QR code for 3 jobs

📢 We have not 1 but 3 clinical/patient-facing jobs working with #mitoCAMB on the #LifeArc #raredisease centre for #mito diseases.

1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator

Join us! Links below.

Description of 3 job advertisements and the MitoCAMB team

All the jobs, all in one place!!

Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells - Acta Neuropathologica Communications Dominant optic atrophy (DOA) is the most common inherited optic neuropathy, characterised by the selective loss of retinal ganglion cells (RGCs). Over 60% of DOA cases are caused by pathogenic variant...

Some nice work with translational potential: links.springernature.com/f/a/GeMY0gc0...